Position in NBIX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$730,366
+$103,052 QoQ
Shares Held
5,544
+25.3% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026CIBC Asset Management Inc holds $45,054,973 across 12 Drug Manufacturers - Specialty & Generic names. NBIX ranks #6 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
270,642 | $31,992,590 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
148,384 | $4,469,326 | |
| 3 | VTRS |
Viatris Inc
|
257,647 | $3,480,810 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
2,465 | $1,461,695 | |
| 5 | BHC |
Bausch Health Companies Inc.
|
250,795 | $1,354,293 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
This page
|
5,544 | $730,366 | |
| 7 | HLN |
Haleon plc
|
53,465 | $535,184 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
15,695 | $375,581 |
All Filings in NBIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $730,366 | 5,544 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $627,314 | 4,423 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $439,810 | 3,133 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $393,786 | 3,133 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $474,252 | 4,288 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $556,647 | 4,078 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $413,755 | 3,591 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $468,078 | 3,400 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $447,826 | 3,247 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $426,902 | 3,240 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $390,262 | 3,469 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $322,600 | 3,421 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $345,969 | 3,418 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $369,427 | 3,093 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $452,029 | 4,256 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $413,705 | 4,244 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $403,406 | 4,303 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $364,442 | 4,279 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $369,828 | 3,856 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $342,371 | 3,518 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $341,542 | 3,512 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,365,479 | 14,246 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $1,291,236 | 13,428 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $411,750 | 3,375 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $292,106 | 3,375 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||